insights_auto
Why is ORX up 2,67%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,08 SEK
arrow_upward
+2,67%(+0,028) 1D
10-ноя., 17:29:51 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,06 SEK
High
1,15 SEK
Low
0,91 SEK
Mkt. cap
377,25 млн
Avg. vol.
582,45 миң
Volume
956,12 миң
P/E ratio
0,05
52-wk high
22,55 SEK
52-wk low
0,81 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,06 SEK
High
1,15 SEK
Low
0,91 SEK
Mkt. cap
377,25 млн
Avg. vol.
582,45 миң
Volume
956,12 миң
P/E ratio
0,05
52-wk high
22,55 SEK
52-wk low
0,81 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
1 саат мурун
S&P 500 Top Movers: Today's US Session Gainers and Losers
Yahoo Finance
·
1 саат мурун
Is the S&P 500 Heading for a Correction?
FXStreet
·
10 саат мурун
S&P 500: Tech rebound drives strong gains – Deutsche Bank
FOREX.com
·
2 саат мурун
S&P 500 forecast: tech rebound faces CPI test | Technical Tuesday
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com